PHYSICIAN NOTES: You Could Have An Easier Time Billing For Off-Label Cancer Drug Uses Soon

Why This Topic Matters

The article brings together several developments that can affect coverage decisions, administrative workflow, and compliance risk in physician practices. It is useful for readers who monitor CMS guidance, Medicare-related billing issues, and broader payer or enforcement trends.

Article Sections

1. Coverage policy and off-label cancer drug use

   Summarizes a policy discussion involving Medicare coverage for certain cancer drug uses and related recommendations for insurers and contractors.

2. CMS enrollment form availability

   Notes a CMS update about online access to enrollment forms and related administrative convenience for providers.

3. Litigation involving federal law and insurer payment disputes

   Reviews brief updates on federal court matters tied to a legislative challenge and a class action involving claims processing and physician payments.

4. Fraud and billing enforcement cases

   Covers allegations and prosecutions involving Medicare billing, medical testing, documentation, and related compliance concerns.

5. CMS guidance on home health oversight and plan of care issues

   Summarizes CMS guidance addressing who may sign or bill for certain home health-related services.

6. CMS transmittal on lumbar artificial disk replacement coverage

   Notes a coverage update concerning a lumbar spine procedure and an age-based Medicare noncoverage determination.